J. J. Finkelstein, President and CEO at REGENERX BIOPHARMACEUTICALS INC (RGN), sold 143,000 shares at $2.80 ($350K) on 2006-05-26, disclosed to the SEC on 2006-05-30.
Open-market sale of $350k RGN by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 18,000 | $0 | 0.0% |
| 2 | $2.80 | 125,000 | $350K | 100.0% |
| Total | $2.45 avg | 143,000 | $350K | 100% |
| Filing → |